Showing results (841-850 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|October 11, 1991
Polysomnographic characteristics of neuroleptic-induced akathisiaJ F Lipinski, J I Hudson, S L Cunningham, et al.Clinical Neuropharmacology|June 1, 1991
Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?E Melamed, A Achiron, A Shapira, et al.Clinical Neuropharmacology|June 5, 2007
Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapyAchilleas Attilakos, Konstantinos A Voudris, Eustathia Katsarou, et al.Clinical Neuropharmacology|April 7, 2007
Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and reviewIván Lerma-Carrillo, Juan D Molina, Teresa Cuevas-Durán, et al.Clinical Neuropharmacology|December 1, 1991
Neurobiological mechanisms of opioid tolerance and dependenceE Collin, F CesselinClinical Neuropharmacology|July 15, 2004
Accuracy of objective ambulatory accelerometry in detecting motor complications in patients with Parkinson diseaseJ I Hoff, V van der Meer, J J van HiltenClinical Neuropharmacology|July 15, 2004
Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson diseaseChuantao Jiang, Xinhua Wan, Joseph Jankovic, et al.Clinical Neuropharmacology|July 15, 2004
Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepinessJonathan R L Schwartz, Michael T Nelson, Elliott R Schwartz, et al.Clinical Neuropharmacology|March 30, 2005
Psychotropic drug interactions with valproateJessica Fleming, Manoranjenni ChettyClinical Neuropharmacology|June 21, 2005
Use of ziprasidone in parkinsonian patients with psychosisJuan Carlos Gómez-Esteban, Juan J Zarranz, Fernando Velasco, et al.Pageof 236